Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button


Home > Press > Apogee Files Form 10-KSB/A

Apogee Technology, Inc. (AMEX: ATA), a nanotechnology and micro-electrical mechanical systems company that designs, develops and commercializes drug delivery and sensor systems, previously issued its Annual Report on Form 10-KSB for the fiscal year ended December 31, 2006 and is amending the 10-KSB to include, among other items, the Part III information regarding management and its compensation. Apogee is currently in the process of scheduling its 2007 Annual Meeting and preparing its Proxy and Notice to Stockholders. In compliance with the AMEX Company Guide Rule 610(b), the Company is disclosing that its previously issued audit report for the fiscal year ended December 31, 2006, contains a going concern qualification. There is no change or amendment to the financial statements as originally filed.

Apogee Files Form 10-KSB/A

NORWOOD, MA | Posted on April 27th, 2007


About Apogee Technology, Inc.
Apogee Technology designs, develops and commercializes proprietary medical device and sensor products using its micro-electrical mechanical systems ("MEMS") and nanotechnology for the medical, automotive, industrial and consumer markets. The Company is developing its PyraDerm™ solution for enhanced intradermal drug delivery and has introduced a family of pressure sensors under the Sensilica® brand. Apogee's goal is to provide value-added and cost-saving solutions for our customers and, in so doing, become a global leader in the sensor and medical device fields. For more information please visit our web site at: .

PyraDerm™ and Sensilica® are trademarks of Apogee Technology, Inc. All other product names noted herein may be trademarks of their respective holders. Certain statements made herein that use the words "anticipate," "may,""hope," "estimate," "project," "will," "intend," "plan," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve the design, development and production efforts of our PyraDerm™ and Sensilica® technologies, known and unknown risks and uncertainties, which could cause the actual results, performance or achievements of the Company to be materially different from those that may be expressed or implied. Please refer to the company's risk factors as set forth in the Company's filings with the Securities and Exchange Commission, including its reports on Forms 10-KSB and 10-QSB.

For more information, please click here

Apogee Investor Contact:
Kelly Black
Premier Funding & Financial Marketing

Copyright © Market Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press


Arrowhead to Present at Upcoming Conferences October 8th, 2015

Harris & Harris Group Portfolio Company, D-Wave Systems, Announces Multi-Year Agreement to Provide Its Technology to Google, NASA and USRA's Quantum Artificial Intelligence Lab October 6th, 2015

Harris & Harris Group Announces Receipt of Milestone Payment From Acquisition of Molecular Imprints by Canon October 5th, 2015

Accelerator Corporation Completes $62.8 Million Oversubscribed Financing September 30th, 2015


Controllable protein gates deliver on-demand permeability in artificial nanovesicles October 9th, 2015

Faster design -- better catalysts: New method facilitates research on fuel cell catalysts October 9th, 2015

Performance of Polymeric Nanoparticles as Gene Carriers Studied by Iranian, Dutch Scientists October 9th, 2015

Newly discovered 'design rule' brings nature-inspired nanostructures one step closer: Computer sims and microscopy research at Berkeley Lab yield first atomic-resolution structure of a peptoid nanosheet October 8th, 2015

Financial Reports

Small but heading for the big time: Nanobiotix half year results for the six months ended 30 June 2015, in line with expectations: Major clinical achievements and corporate developments August 28th, 2015

Nanostart AG: First-half figures 2015 published and new supervisory board elected : Publication of first-half figures 2015 - Shareholders' meeting elected new supervisory board August 22nd, 2015

Industrial Nanotech, Inc. CEO Announces PCAOB Audit, Next Generation Of Current Products, New Products, New Website, New Global Outreach Program August 11th, 2015

Harris & Harris Group Reports Financial Statements as of June 30, 2015, and Announces a Stock Repurchase Program August 10th, 2015

The latest news from around the world, FREE

  Premium Products
Only the news you want to read!
 Learn More
University Technology Transfer & Patents
 Learn More
Full-service, expert consulting
 Learn More

Nanotechnology Now Featured Books


The Hunger Project

Car Brands
Buy website traffic